
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of 1 Epidemiology and Biostatistics, 2 Genetics, 3 Pathology and 4 Medicine, 5 Case Comprehensive Cancer Center, 6 Center for Human Genetics, 7 University Hospitals of Cleveland/Case Western Reserve University and Howard Hughes Medical Institute, and Cleveland, Ohio and the 8 University of British Columbia, Vancouver, BC, Canada
Requests for reprints: Denise Daley, 166 Burrard Building, 1081 Burrard Street, Vancouver, BC, Canada V6Z1Y6. Phone: 604-682-2344; Fax: 604-806-8351. E-mail: ddaley{at}mrl.ubc.ca
Our analysis definitely excludes the possibility of the TGFBR1*6A allele increasing the risk of colorectal neoplasia in our sample population. A recent study validating linkage of colorectal cancer to chromosome 9q also excluded the TGFBR1*6A allele as a disease-causing variant in that sample. We conclude that there remains an unidentified susceptibility locus in the region 9q22.2-31.2. (Cancer Epidemiol Biomarkers Prev 2007;16(5):8924)
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |